Thymosin Alpha-1: the peptide in immunology research
Thymosin Alpha-1 is a 28–amino-acid peptide originally identified in thymic tissue and now produced synthetically as a research reference material. This overview is educational and describes the research field only.
What it is
The peptide takes its name from the thymus, the organ central to immune-cell development. In research it is a defined sequence used to study peptide behaviour in immunology models.
How it is studied
Thymosin Alpha-1 is referenced across a broad immunology literature. As with every compound we supply, that literature describes laboratory and clinical research — it is not a basis for use, and nothing here should be read as guidance.
How Thymosin Alpha-1 is handled in the laboratory
Like our other reference materials, it is supplied as a lyophilised (freeze-dried) powder in a sealed vial. Researchers reconstitute it with a diluent such as bacteriostatic water before use. Every batch is independently verified by HPLC, mass spectrometry and an endotoxin (LAL) screen; see our testing standards or look a batch up on Verify a Batch.
Related reading
For laboratory research use only. Not for human or animal consumption; not a medicine, food, supplement or cosmetic. Nothing on this page is medical advice, a recommendation, or a claim of any effect in humans or animals.
See how our compounds are tested
Independent HPLC purity and Mass Spec identity data, published per compound.